NewAmsterdam Pharma Company NV Ordinary Shares
Price & Volume
Stats
See moreOpen | $27.94 |
Previous Close | $27.49 |
Day Range | $27.04-$27.94 |
52W Range | $21.23-$42.20 |
Market Cap | $3.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $22.5M |
Revenue Growth (YoY) | 2.1% |
Gross Profit (12 Mos) | $22.5M |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • 21 days ago
Attovia Therapeutics Appoints John W. Smither to Board of Directors
Yahoo Finance • 29 days ago
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
Yahoo Finance • last month
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Michael Harvey Davidson FACC, Facp., M.D. |
Address | Gooimeer 2-35, Naarden, Netherlands, 1411 DC |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |